2020 - Designing and Sustaining New and Existing Product Stability Testing Program
Date2020-04-23 - 2020-04-24
Deadline2020-04-13
VenueTampa, FL, USA - United States
KeywordsNDA submission; Documentation Methods; FDA's Drug Stability Testing
Topics/Call fo Papers
This seminar will provide the detailed requirements applicable to the FDA’s and 21CFR 514.1(b)(5)(x) expectations which states that “an applicant should submit data from stability studies that have been completed as well as information about studies that are underway to substantiate the request for a specific expiration date and provide information on the stability of the drug products” FDA’s Guidance for Industry. For this reason, it is important to have clarity and understanding of how to apply this regulation prior to the initiation of a new product stability testing program which includes the protocol design, testing, storage, data management, trending and expiration dating extrapolations and expectations for products in a new or existing IND or NDA application process.
Other CFPs
- A Review of the Conditions of Participation for Utilization Review: Are you Compliant?
- Latin America – Understanding Regulatory Compliance Requirements Across the Life Science Industry (Pharmaceuticals, Biologics, Medical Devices, IVDs)
- Pharmacovigilance System Master File (PSMF) - A Practical Approach to Design and Implementation Globally
- 12th International Conference on Information Management and Engineering (ICIME 2020)
- International Conference on Science, Engineering & Management (ICSEM 2020)(SCOPUS (Elsevier), Web of Science™ Core Collection, ESCI indexed)
Last modified: 2020-02-13 16:12:26